• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 患者尸检中急性肺栓塞的患病率。

Prevalence of Acute Pulmonary Embolism at Autopsy in Patients With COVID-19.

机构信息

Department of Translational Medicine, Section of Internal and Cardio-Respiratory Medicine, University of Ferrara, Ferrara, Italy.

Department of Cardiovascular Diseases, University Hospitals Leuven, Leuven, Belgium.

出版信息

Am J Cardiol. 2022 May 15;171:159-164. doi: 10.1016/j.amjcard.2022.01.051. Epub 2022 Mar 8.

DOI:10.1016/j.amjcard.2022.01.051
PMID:35277253
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8902912/
Abstract

To date, the actual prevalence of acute pulmonary embolism (PE) in patients with SARS-CoV-2 infection remains unknown, as systematic screening for PE is cumbersome. We performed a systematic review and meta-analysis on autoptic data to estimate the prevalence of histopathologic findings of acute PE and its relevance as a cause of death on patients with COVID-19. We searched MEDLINE-PubMed and Scopus to locate all articles published in the English language, up to August 10, 2021, reporting the autoptic prevalence of acute PE and evaluating PE as the underlying cause of death in patients with COVID-19. The pooled prevalence for both outcomes was calculated using a random-effects model and presenting the related 95% confidence interval (CI). Statistical heterogeneity was measured using the Higgins I statistic. We analyzed autoptic data of 749 patients with COVID-19 (mean age 63.4 years) included in 14 studies. In 10 studies, based on 526 subjects (mean age 63.8 years), a random-effect model revealed that autoptic acute PE findings were present in 27.5% of cases (95% CI 15.0 to 45.0%, I 89.9%). Conversely, in 429 COVID-19 subjects (mean age 64.0 years) enrolled in 9 studies, acute PE was the underlying cause of death in 19.9% of cases (95% CI 11.0 to 33.3%, I 83.3%). Autoptic findings of acute PE in patients with COVID-19 are present in about 30% of subjects, whereas a venous thromboembolic event represents the underlying cause of death in about 1 of 4 patients.

摘要

截至目前,SARS-CoV-2 感染患者中急性肺栓塞(PE)的实际患病率尚不清楚,因为对 PE 的系统筛查很繁琐。我们对尸检数据进行了系统回顾和荟萃分析,以评估 COVID-19 患者中急性 PE 的组织病理学发现的患病率及其作为死亡原因的相关性。我们在 MEDLINE-PubMed 和 Scopus 上搜索了截至 2021 年 8 月 10 日以英文发表的所有文章,报道了急性 PE 的尸检患病率,并评估了 PE 作为 COVID-19 患者的潜在死亡原因。使用随机效应模型计算了这两个结果的合并患病率,并呈现了相关的 95%置信区间(CI)。使用 Higgins I 统计量衡量统计异质性。我们分析了 14 项研究中纳入的 749 例 COVID-19 患者(平均年龄 63.4 岁)的尸检数据。在 10 项研究中,基于 526 名患者(平均年龄 63.8 岁),随机效应模型显示尸检急性 PE 发现存在于 27.5%的病例中(95%CI 15.0 至 45.0%,I 89.9%)。相反,在纳入 9 项研究的 429 名 COVID-19 患者(平均年龄 64.0 岁)中,急性 PE 是 19.9%病例的潜在死亡原因(95%CI 11.0 至 33.3%,I 83.3%)。COVID-19 患者的尸检中急性 PE 发现存在于大约 30%的患者中,而静脉血栓栓塞事件是大约 1/4 患者的潜在死亡原因。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3dc/8902912/e42f05183a39/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3dc/8902912/f8cb18a6b377/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3dc/8902912/05f84e1c732e/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3dc/8902912/e42f05183a39/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3dc/8902912/f8cb18a6b377/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3dc/8902912/05f84e1c732e/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3dc/8902912/e42f05183a39/gr3_lrg.jpg

相似文献

1
Prevalence of Acute Pulmonary Embolism at Autopsy in Patients With COVID-19.COVID-19 患者尸检中急性肺栓塞的患病率。
Am J Cardiol. 2022 May 15;171:159-164. doi: 10.1016/j.amjcard.2022.01.051. Epub 2022 Mar 8.
2
Incidence of acute pulmonary embolism in COVID-19 patients: Systematic review and meta-analysis.新型冠状病毒肺炎患者急性肺栓塞的发生率:系统评价和荟萃分析。
Eur J Intern Med. 2020 Dec;82:29-37. doi: 10.1016/j.ejim.2020.09.006. Epub 2020 Sep 17.
3
[Incidence of acute pulmonary embolism in hospitalized COVID-19 Italian patients. A pooled meta-analysis].[意大利住院COVID-19患者急性肺栓塞的发病率。一项汇总荟萃分析]
G Ital Cardiol (Rome). 2022 Apr;23(4):233-243. doi: 10.1714/3766.37530.
4
Higher prevalence of pulmonary macrothrombi in SARS-CoV-2 than in influenza A: autopsy results from 'Spanish flu' 1918/1919 in Switzerland to Coronavirus disease 2019.SARS-CoV-2 肺内大血栓的发生率高于甲型流感:瑞士 1918/1919 年“西班牙流感”至 2019 年冠状病毒病的尸检结果。
J Pathol Clin Res. 2021 Mar;7(2):135-143. doi: 10.1002/cjp2.189. Epub 2020 Nov 13.
5
COVID-19 patients with acute pulmonary embolism have a higher mortality risk: systematic review and meta-analysis based on Italian cohorts.COVID-19 合并急性肺栓塞患者的死亡率风险更高:基于意大利队列的系统评价和荟萃分析。
J Cardiovasc Med (Hagerstown). 2022 Dec 1;23(12):773-778. doi: 10.2459/JCM.0000000000001354. Epub 2022 Aug 19.
6
Prevalence of Pulmonary Embolism in COVID-19: a Pooled Analysis.新型冠状病毒肺炎患者中肺栓塞的患病率:一项汇总分析
SN Compr Clin Med. 2020;2(12):2722-2725. doi: 10.1007/s42399-020-00605-5. Epub 2020 Oct 28.
7
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
8
High rates of pulmonary artery occlusions in COVID-19. A meta-analysis.COVID-19 患者肺动脉闭塞发生率较高。一项荟萃分析。
Eur J Clin Invest. 2021 Jan;51(1):e13433. doi: 10.1111/eci.13433. Epub 2020 Oct 31.
9
Prevalence of acute pulmonary embolism among patients in a general hospital and at autopsy.综合医院患者及尸检中急性肺栓塞的患病率
Chest. 1995 Oct;108(4):978-81. doi: 10.1378/chest.108.4.978.
10
COVID-19 and Venous Thromboembolism: A Meta-analysis of Literature Studies.COVID-19 和静脉血栓栓塞症:文献研究的荟萃分析。
Semin Thromb Hemost. 2020 Oct;46(7):763-771. doi: 10.1055/s-0040-1715456. Epub 2020 Sep 3.

引用本文的文献

1
SARS-CoV-2 (COVID-19) Experience at an Academic Medical Examiner's Office.学术法医办公室的新型冠状病毒(COVID-19)相关情况
Acad Forensic Pathol. 2024 May 30;14(3):87-107. doi: 10.1177/19253621231224532. eCollection 2024 Sep.
2
A COVID-19 specific multiparametric and ECG-based score for the prediction of in-hospital mortality: ELCOVID score.用于预测住院死亡率的 COVID-19 特定多参数和基于心电图的评分:ELCOVID 评分。
Intern Emerg Med. 2024 Aug;19(5):1279-1290. doi: 10.1007/s11739-024-03599-3. Epub 2024 Apr 23.
3
Antiplatelet therapy prior to COVID-19 infection impacts on patients mortality: a propensity score-matched cohort study.

本文引用的文献

1
Clinical characteristics and outcomes of venous thromboembolism in patients hospitalized for COVID-19: Systematic review and meta-analysis.因新冠肺炎住院患者静脉血栓栓塞症的临床特征及预后:系统评价与荟萃分析
Thromb Update. 2021;2:100037. doi: 10.1016/j.tru.2021.100037. Epub 2021 Mar 19.
2
Mortality and risk factors associated with pulmonary embolism in coronavirus disease 2019 patients: a systematic review and meta-analysis.新冠肺炎患者肺栓塞的死亡率及相关风险因素:系统评价和荟萃分析。
Sci Rep. 2021 Aug 6;11(1):16025. doi: 10.1038/s41598-021-95512-7.
3
COVID-19 and Sudden Unexpected Community Deaths in Lusaka, Zambia, Africa - A Medico-Legal Whole-Body Autopsy Case Series.
COVID-19 感染前的抗血小板治疗对患者死亡率的影响:一项倾向评分匹配队列研究。
Sci Rep. 2024 Feb 28;14(1):4832. doi: 10.1038/s41598-024-55407-9.
4
Postmortem Minimally Invasive Autopsy in Critically Ill COVID-19 Patients at the Bedside: A Proof-of-Concept Study at the ICU.危重症 COVID-19 患者床边尸检微创尸检:重症监护病房的概念验证研究
Diagnostics (Basel). 2024 Jan 30;14(3):294. doi: 10.3390/diagnostics14030294.
5
CXCL10 May Be Responsible for Susceptibility to Pulmonary Embolism in COVID-19 Patients.CXCL10可能是COVID-19患者易患肺栓塞的原因。
J Inflamm Res. 2023 Oct 31;16:4913-4924. doi: 10.2147/JIR.S431212. eCollection 2023.
6
A Pictorial Essay Describing the CT Imaging Features of COVID-19 Cases throughout the Pandemic with a Special Focus on Lung Manifestations and Extrapulmonary Vascular Abdominal Complications.一篇图文并茂的文章,描述了新冠疫情期间新冠肺炎病例的CT成像特征,特别关注肺部表现和肺外血管腹部并发症。
Biomedicines. 2023 Jul 26;11(8):2113. doi: 10.3390/biomedicines11082113.
7
Impact of Alteplase on Mortality in Critically Ill Patients with COVID-19 and Pulmonary Embolism.新冠肺炎合并肺栓塞危重症患者使用阿替普酶对死亡率的影响。
Viruses. 2023 Jul 7;15(7):1513. doi: 10.3390/v15071513.
8
Postmortem lung and heart examination of COVID-19 patients in a case series from Jordan.对约旦一系列病例中新冠病毒肺炎患者进行的尸检肺和心脏检查。
J Pathol Transl Med. 2023 Mar;57(2):102-112. doi: 10.4132/jptm.2023.01.30. Epub 2023 Mar 14.
9
Clinical, laboratory and immunohistochemical characterization of in situ pulmonary arterial thrombosis in fatal COVID-19.COVID-19 致死患者肺部原位肺动脉血栓的临床、实验室和免疫组化特征。
Thromb Res. 2022 Nov;219:95-101. doi: 10.1016/j.thromres.2022.09.012. Epub 2022 Sep 17.
10
Venous Thromboembolic Disease in COVID-19, Pathophysiology, Therapy and Prophylaxis.COVID-19中的静脉血栓栓塞性疾病:病理生理学、治疗与预防
Int J Mol Sci. 2022 Sep 8;23(18):10372. doi: 10.3390/ijms231810372.
非洲赞比亚卢萨卡的 COVID-19 和突发性意外社区死亡 - 一项法医学全尸解剖病例系列研究。
Int J Infect Dis. 2021 Aug;109:160-167. doi: 10.1016/j.ijid.2021.07.001. Epub 2021 Jul 5.
4
SARS-CoV-2, myocardial injury and inflammation: insights from a large clinical and autopsy study.SARS-CoV-2、心肌损伤和炎症:来自一项大型临床和尸检研究的见解。
Clin Res Cardiol. 2021 Nov;110(11):1822-1831. doi: 10.1007/s00392-021-01910-2. Epub 2021 Jul 19.
5
Cardiac pathology in COVID-19: a single center autopsy experience.COVID-19 患者的心脏病理学:一项单中心尸检研究。
Cardiovasc Pathol. 2021 Sep-Oct;54:107370. doi: 10.1016/j.carpath.2021.107370. Epub 2021 Jul 14.
6
Post-mortem examination of Hospital Inpatient COVID-19 Deaths in Lusaka, Zambia - A Descriptive Whole-body Autopsy Series.赞比亚卢萨卡医院 COVID-19 住院患者死后检查——一项描述性的全身解剖系列研究。
Int J Infect Dis. 2021 Jul;108:363-369. doi: 10.1016/j.ijid.2021.06.013. Epub 2021 Jun 17.
7
A cohort autopsy study defines COVID-19 systemic pathogenesis.一项队列尸检研究定义了 COVID-19 的全身发病机制。
Cell Res. 2021 Aug;31(8):836-846. doi: 10.1038/s41422-021-00523-8. Epub 2021 Jun 16.
8
Cause of death based on systematic post-mortem studies in patients with positive SARS-CoV-2 tissue PCR during the COVID-19 pandemic.基于在 COVID-19 大流行期间 SARS-CoV-2 组织 PCR 阳性患者的系统尸检研究的死亡原因。
J Intern Med. 2021 Sep;290(3):655-665. doi: 10.1111/joim.13300. Epub 2021 May 20.
9
Pathophysiology of SARS-CoV-2: the Mount Sinai COVID-19 autopsy experience.SARS-CoV-2 的病理生理学:西奈山 COVID-19 尸检经验。
Mod Pathol. 2021 Aug;34(8):1456-1467. doi: 10.1038/s41379-021-00793-y. Epub 2021 Apr 1.
10
Causes of death and comorbidities in hospitalized patients with COVID-19.COVID-19 住院患者的死亡原因和合并症。
Sci Rep. 2021 Feb 19;11(1):4263. doi: 10.1038/s41598-021-82862-5.